Standard BioTools Inc
NASDAQ:LAB
Standard BioTools Inc
NASDAQ:LAB
Price:
2.465 USD
-1.79%
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one
LAB
stock under the Base Case scenario is
3.952
USD.
Compared to the current market price of 2.465 USD,
Standard BioTools Inc
is
Undervalued by 38%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LAB
Relative Value
Base Case
3.952
USD
Undervaluation 38%
Valuation Multiples
Multiples Across Competitors
LAB Competitors Multiples
Standard BioTools Inc Competitors
Standard BioTools Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Standard BioTools Inc
NASDAQ:LAB
|
950.9m USD | 8.9 | -12.5 | -17.6 | -13.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 36.9 | 22.8 | 33.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
184B USD | 4.2 | 22.8 | 16.6 | 20.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.6 | 57.6 | 19.8 | 29 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.9B USD | 6.1 | 33.1 | 26.4 | 31.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.5B USD | 2.7 | 29.9 | 16.3 | 25.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.9 | 26.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.9 | 32.5 | 39.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.4 | 16.9 | 26 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.5 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
